Skip to Content


Main Content

Outcomes of CD19 CAR-T in patients who achieve complete remission prior to lymphodepletion in patients with aggressive non-Hodgkins lymphoma.

Study #: LY22-01c

Study Status: Published


2023, ASH (Oral)

Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: A Center for International Blood and Marrow Transplant Research Analysis.


Wang TP, Savani B, Ahn KW, Shadman M, Kaur M, Ahmed N, Bacher U, Cerny J, Chen A, Epperla N, Frigault M, Grover N, Haverkos B, Hill B, Hossain N, Iqbal M, Jain T, Kremm MM, Maakaron J, Modi D, Alhaj Moustafa M, Riedell P, Sica RA, Sureda A, Wudhikarn K, Herrera AF, Sauter J, Hamadani M, Jimenez-Jimenez A.

Leukemia. 2024, May 15: (): . doi: 10.1038/s41375-024-02242-6. Epub 2024, May 15. PMCID:.


PMID: 38750138